Application of B-type diuretic peptide in prognosis analysis of acute pulmonary embolism
-
Last Update: 2016-09-23
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, researchers from respiratory department of Affiliated Hospital of Qinghai University published papers to study the value and application of plasma B-type diuretic peptide (BNP) in the prognosis evaluation of acute pulmonary embolism (APE) It is pointed out that BNP concentration in plasma can be used as an index for risk stratification and prognosis evaluation of ape to guide clinical diagnosis and treatment This article was published in the 22nd issue of Jilin medicine in 2014 120 patients with ape were diagnosed by spiral CT and pulmonary arteriography (CTPA), and the BNP level in plasma was measured within 6 hours Then the correlation between BNP level and the incidence of massive embolism, mortality, pulmonary hypertension and other clinical risk symptoms was analyzed There were 56 cases with BNP > 150 ng / L and 64 cases with BNP < 150 ng / L The incidence of right ventricular dysfunction, pulmonary hypertension and right ventricular overload in ape patients with elevated BNP was significantly higher than that in ape patients with normal BNP The incidence of syncope, cardiogenic shock and mortality in ape patients with BNP increased were significantly higher than those in ape patients with BNP normal Related links: http://med.wanfangdata.com.cn/periodic/jlyx-hlb
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
